Related Experiment Video
Updated: Sep 27, 2025
Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection
Published on: February 7, 2025
Early experience with total robotic D2 gastrectomy in a low incidence region: surgical perspectives
Tom Mala1, Dag Førland2, Caroline Skagemo2
1Dep. of Gastrointestinal and Pediatric Surgery, Division of Surgery, Inflammatory Medicine and Transplantation, Oslo University Hospital, Ullevål Hospital, Nydalen, Pb. 4956, 0424, Oslo, Norway. tommenmala@gmail.com.
Background:
Few European centers have reported on robotic gastrectomy for malignancy. We report our early experience with curative-intent total robotic gastrectomy.
Materials And Methods:
The Intuitive Surgery Da Vinci Surgical System Xi 4 armed robot was used. Routine D2 lymphadenectomy was applied.
Results:
Some 27 patients with adenocarcinoma (n = 18), hereditary cancer susceptibility (n = 8) and premalignancy (n = 1) were allocated to robotic gastrectomy, three were excluded due to inoperability during surgery. Median (range) age was 66 (18-87) years, 14 (58.3%) were females and body mass index was 25.5 (22.1-33.5) kg/m2. Total gastrectomy was performed in 19 (79.2%) and subtotal in five (20.8%) patients. One (4.2%) procedure was converted to laparotomy. Procedural time was 273 (195-427) minutes. Three (12.5%) patients were reoperated within 30 days, one (4.2%) died. Serious complications (Clavien Dindo IIIb or more) occurred in three (12.5%) patients. Postoperative hospital stay was 10 (6-43) days. Fourteen of 16 (87.5%) patients with adenocarcinoma/premalignancy received radical resections. The median number of harvested lymph nodes was 20 (11-34). Eleven (73.3%) patients with adenocarcinoma had T3/T4 tumors and 6 (40%) had TNM stage III or more.
Conclusion:
Total robotic D2 gastrectomy appears feasible and safe during early introduction in a low incidence region.
